Hoertkorn Richard Charles Merck & Co., Inc. Transaction History
Hoertkorn Richard Charles
- $192 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,868Shares Held
1.97BCall Options Held
29.9MPut Options Held
30.7M-
Vanguard Group Inc Valley Forge, PA252MShares$21.9 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$18 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.3 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.67 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.11 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $220B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...